Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129118) titled 'Safety and eFfectiveness of cathetER ablation for Atrial Fibrillation with intracerebral hemorrhage' on July 31.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Anzhen Hospital, Capital Medical University
Condition:
Atrial fibrillation combined with cerebral hemorrhage
Intervention:
Catheter ablation group:Pulsed field ablation (PFA) treatment
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-06
Target Sample Size: Catheter ablation group:323;Conventional treatment group:323;
Countries of Recruitment:
China
To know more, visit https://www....